CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Affimed NV Company Snapshot
Affimed NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Affimed NV with three other companies in this sector in UNITED STATES : Dicerna Pharmaceuticals Inc (2019 sales of $23.90 million of which 100% was RNA Interference (RNAi) Therapeutics), Gevo, Inc. ($24.49 million of which 90% was Gevo Development/Agri-Energy), and Epizyme Inc ($23.80 million of which 100% was one reportable segment).

Sales Analysis. Affimed NV reported sales of $23.91 million for the year ending December of 2019. This represents a decrease of 14.5% versus 2018, when the company's sales were $27.97 million. Contributing to the drop in overall sales was the 15.2% decline in Collaboration Revenue, from $25.94 million to $22.00 million. There were also decreases in sales in Service Revenue (down 5.7% to $1.91 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Affimed NV
  Stock Performance Chart for Affimed NV
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 3.30
(Figures in U.S. Dollars)
1 Week -7.0%   13 Weeks -0.9%  
4 Weeks -16.2%   52 Weeks 16.6%  
 
Affimed NV Key Data:
  Ticker: AFMD Country: Germany
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 23,909,790
(Year Ending Jan 2020).
Employees: 128
  Currency: U.S. Dollars Market Cap: 303,434,673
  Fiscal Yr Ends: December Shares Outstanding: 91,949,901
  Share Type: Common Closely Held Shares: 5,783,091
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.